Veille documentaire MTPH

Médecine du travail du personnel hospitalier

Serogroup B meningococcal vaccines-an unfinished story

Auteur     Manish Sadarangani
Auteur     Andrew J Pollard
Résumé     Most invasive meningococcal disease in developed countries is caused by Neisseria meningitidis with a serogroup B capsule. However, despite availability of vaccines for other serogroups since the 1960s, no serogroup B vaccine exists. In this Review we look at the development of serogroup B vaccines over the past 40 years. Outer membrane vesicle vaccines have been successfully used to control geographically isolated epidemics, but most have not been highly immunogenic in young children or provided broad cross-protection from infections with other strains. Vaccines based on subcapsular antigens have recently produced promising results in early clinical trials, and the disease burden might be substantially reduced over the next few years.
Publication     The Lancet Infectious Diseases
Volume     10
Numéro     2
Pages     112-124
Date     Feb 2010

Export bibliographique

Chercher cette référence sur : Google Scholar, Worldcat


Laisser une réponse

Vous devez etre connectez Pour poster un commentaire